Compare Pfizer Inc (PFE) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Star Bulk Carriers Corp — how do they compare? Pfizer Inc trades at $28.1 (market cap $158.56B), while Star Bulk Carriers Corp trades at $29.78 (market cap $3.54B). The key difference: Pfizer Inc is far larger — about 44.8× Star Bulk Carriers Corp's market cap, and Pfizer Inc pays the higher dividend (6.18%). Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and Star Bulk Carriers Corp for 24 Days on average.
| PFE | SBLK | |
|---|---|---|
Market Cap | $158.56B | $3.54B |
Volume | 44,138,282 | 1,437,622 |
Sector | Health | Industrials |
52-Week High | $29.02 | $32.49 |
52-Week Low | $23.67 | $16.79 |
Typical Hold Time | 158 Days | 24 Days |
Enterprise Value | $210.06B | $4.22B |
Dividend Yield | 6.18% | 6.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
Star Bulk Carriers (SBLK) trades at $29.69, down 0.57% on the day, with a bearish technical signal despite strong fundamental performance. The company delivered three consecutive earnings beats, with Q2 2026 EPS of $1.21 exceeding expectations by 27%. Revenue grew 45% year-over-year, and management maintains a 100% free cash flow distribution policy, recently declaring a $0.90 dividend payable September 3, 2026.
SBLK presents a compelling value opportunity with attractive valuation metrics (P/E 11.95, P/S 2.86) and strong profitability (23.87% net margin). Analyst consensus leans bullish (58% buy ratings), but technical weakness and shipping market volatility pose near-term risks. The stock's 61% annual gain reflects strong operational execution, though current price action suggests consolidation after recent highs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
